SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " nixon " 72 found 🔀 AI-powered Shuffle
UNF poll gives Ashley Moody 4-point lead over Angie Nixon as turnout takes center stage
Nixon is polling well among Dems and up 15 points with NPAs, but Republicans' voter registration advantage keeps Moody in front.
Green Bay Packers: Keisean Nixon calls his body ‘my resume’
Keisean Nixon will play Sunday night against the Dallas Cowboys, Green Bay Packers coach Matt LaFleur said Friday. The cornerback missed Wednesday’s practice with a groin injury, then practiced on a limited basis Thursday and Friday. Nixon carries no game status on the final injury report, according to the Packers. The other starting cornerback, Brandon [...]
Thousands rally with Bernie Sanders and Angie Nixon in rainy Ybor City
Their message was helping the working class deal with rising inflation, a lack of health care and unlimited campaign financing by "the oligarchy."
Bernie Sanders Visits Florida to Campaign With Angie Nixon
Senator Bernie Sanders of Vermont has made a point of investing in Republican-leaning states. He rallied in Tampa for Ms. Nixon, the underdog Democratic nominee for Florida Senate.
Packers returning CB Keisean Nixon (groin) to practice on Thursday
Big injury news: Cornerback Keisean Nixon, who missed Wednesday's practice, will practice Thursday ahead of Sunday's matchup with the Cowboys.
Why being from California is no longer a presidential asset
California was a springboard for the White House ambitions of Nixon and Reagan. Now it's an anchor on the aspirations of Gavin Newsom, Kamala Harris and others.
Christine Baranski and Cynthia Nixon tease ‘The Gilded Age’ season 4: ‘Serious complications in the household’
‘The Gilded Age’ season 4 sees the characters dealing with some big changes. Christine Baranski and Cynthia Nixon exclusively share what’s to come for the HBO series: ‘She’ll do what she needs to do to save her and her family members.’
Contests for Florida governor, senator offer different strategies for handling race
It’s a reflection of a difficult reality for Black candidates like Byron Donalds and Angie Nixon, especially in a Southern state, experts say: Progressives may motivate their base by engaging on race, but conservatives risk alienating…
Jolly, Nixon make pitch to Black voters in Miami Gardens ahead of elections
David Jolly and Angie Nixon pitched economic opportunity and civil rights to Black voters at U.S. Rep. Federica Wilson’s annual Fireside chat.
Letters: Retain Muñiz | Nixon will protect abuse survivors
Justice Muñiz keeps an open mind, listens to every party, and treats people with professionalism and kindness.
New St. Pete Polls survey has Ashley Moody at 47%, Angie Nixon at 45%, and the Senate race still inside the margin of error
U.S. Sen. Ashley Moody leads Democrat Angie Nixon 47% to 45% in a new St. Pete Polls survey for Florida Politics, a narrow edge for the Republican inside
Biden-era FBI’s ‘Nixonian’ Trump family surveillance draws scrutiny from unlikely corner
Julian Epstein, a former top Democratic official, compared the FBI's tracking of Melania Trump, Barron Trump and Susie Wiles to Nixonian tactics.
Angie Nixon brings a pep rally-style campaign stop to USF Tampa
Nixon fired up the crowd with an energetic case for more government involvement in medical care, college tuition and affordable housing.
U.S. Senate candidate Angie Nixon presses Florida's two senators to protect Haitian TPS holders
Senate Bill 4814, if passed, would extend protections for Haitian nationals who face a forced return amid worsening gang violence, political turbulence, and economic destruction in Haiti. The legislation is stalled in the U.S. Senate.
Vance embodies Nixon’s populist, outsider qualities
There have been countless comparisons between the late President Richard Nixon and President Donald Trump, due to their cunning, guile, and Machiavellian approaches to politics. Nixon himself, in a 1987 letter to Trump, a then-celebrity businessman, saw a political future for the younger man in response to a Phil Donahue Show television appearance. But there’s […]
Democrats slam Ashley Moody amid a heated U.S. Senate race
Earlier this month, Moody declined to debate Nixon, telling Action News Jax she would bring attention to a “self-proclaimed socialist.”
Angie Nixon’s campaign runs through the labor, Civil Rights movements
Nixon’s rise comes as Democrats, Black activists and legal scholars say the gains of the Civil Rights Movement are under attack.
Hannah Einbinder, Susan Sarandon arrested in protest against Netanyahu
Hannah Einbinder and Susan Sarandon were arrested after protesting the arrival of Israeli Prime Minister Benjamin Netanyahu at the United Nations in New York City. Cynthia Nixon, Elliot Page, Indya Moore, Mary Beth Barone, Caleb Hearon and Sarah Sherman were also at the demonstration.
New Stetson Univ. poll casts doubt on blue wave in Florida
Republicans are over 50% in this dataset.
Trump call for supporters to cheat undermines fraud claims
Richard M. Nixon famously declared, 'I am not a crook.' Donald J. Trump, his approval rating slumping toward Nixonian levels, is urging his backers to act like crooks in November's election.
Sunshine State Earthquake? St. Pete Polls shows Ashley Moody, Angie Nixon neck-and-neck in heated Senate race
Both candidates are winning about 45% support from likely voters.
Poll: Ashley Moody 45%, Angie Nixon 45%, and Florida now has two toss-ups at the top of the ticket
U.S. Sen. Ashley Moody and Democratic challenger Angie Nixon are essentially tied in Florida's U.S. Senate race, according to a new St. Pete Polls survey
The Watergate Caper: Richard Nixon and the Death of the American Dream review
Shane O’Sullivan’s documentary weaves archive clips and snippets from films old and new to draw out the highlights of the crisis that rocked the US
From family van to Democratic U.S. Senate contender: Angie Nixon’s unlikely rise
“I told myself, ‘I don’t like bullies, and I will always stand up and push back and fight against bullies,’” Nixon said on Monday’s episode of the State Affairs podcast “Between the Lines With Dara Kam.”
Ashley Moody already has 50% support in new poll of Senate race
Nixon has a narrow path to close the gap, given most voters know who they like already.
Will Angie Nixon drag down the entire Florida Democratic ticket?
Some Democrats see her energizing a largely untapped base of new voters, but Republicans are ready to use her as an anchor down ballot.
Florida Politics: Hope Florida, Nixon-Moody debate?
Florida Governor Ron DeSantis is set to host a forum with several huge names in the Florida Republican Party, such as Attorney General James Uthmeier and GOP Gubernatorial Candidate Byron Donalds. Meanwhile, Angie Nixon is throwing her hat into the ring, challenging U.S. Senator Ashley Moody to a public debate ahead of the general election. POLITICO Reporter and Florida Playbook author Kimberly Leonard joined FOX 35's Garrett Wymer live over Zoom to discuss what's new in Florida politics.
Florida Governor Moves From Solid to Likely Republican
Florida has been a mirage for Democrats during the era of President Donald Trump. Some in the party hoped the Senate race could come online thanks to Alex Vindman’s massive fundraising hauls, but his loss to democratic socialist Angie Nixon effectively took that race off the table.
Packers Could Make ‘High-Profile’ Trade at Roster Cuts
If the Green Bay Packers make a big move before roster cuts, it would likely be a trade or release of cornerback Keisean Nixon, according to Rob Demovsky of ESPN.Demovsky noted that the cornerback room is deep, and it could lead to Nixon being a high-profile move.“If there is going to be a high-profile move […] The post Packers Could Make ‘High-Profile’ Trade at Roster Cuts appeared first on HEAVY.
Fla Dem Sen-nominee Angie Nixon backed abolishing Electoral College, ranked-choice voting in resurfaced clips
Resurfaced clips show Angie Nixon backing abolishing the electoral college, ranked-choice voting, and same-day registration in her Florida Senate bid.
How a Progressive Democrat in Florida Gave Her Party New Hope
Angie Nixon, a state lawmaker from Jacksonville, shocked Democrats in red Florida by soundly defeating her centrist primary opponent. Now comes the hard part.
Did Mexico create a blacklist of journalists and politicians? The president says no
The Mexican government's creation of lists of journalists and opposition figures has stirred memories of the 'enemies list' of the Nixon administration in the U.S.
How the bipartisan data center backlash could reshape politics nationwide
Bipartisan backlash to data centers is spreading nationwide. How could the panicked political response carry lasting consequences? Plus, Democratic socialist Angie Nixon’s upset in the Florida Demo…
Democratic socialist Angie Nixon won the Senate primary in Florida. Can she win in November?
Nixon's upset sets up a long-shot challenge to U.S. Sen. Ashley Moody, a former state attorney general who Gov. Ron DeSantis selected to fill the seat after it was vacated by Marco Rubio, who Trump chose as secretary of state.
A Stunning Win for the Left in Florida: 6 Takeaways from Tuesday’s Primaries
State Representative Angie Nixon, a progressive firebrand, defeated a moderate who dramatically out-raised her with grass-roots enthusiasm. Can it carry her to victory in November?
Angie Nixon wins Florida Democratic primary for U.S. Senate
She will take on incumbent Ashley Moody, who won the Republican primary.
Packers Training Camp Recap: Cornerback competition ramps up
Keisean Nixon, Brandon Cisse, Benjamin St-Juste and Carrington Valentine all played outside corner with the 1s today
Progressive Florida Dem Senate candidate wants to ‘assess’ congressional leadership
Nixon, Vindman seek Democratic nomination for Florida U.S. Senate seat
The winner is expected to take on incumbent Ashley Moody, who is the favorite in the Republican primary.
Reagan’s PATCO Showdown ignited Colorado labor backlash
Forty-five years ago this week: “It’s the old Nixon reaction as far as I’m concerned. He thinks he’s the Great God Almighty and can do no wrong … in the eyes of the public,” said Zelda Bransted, spokesman of the Colorado AFL-CIO. “I sincerely hope it backfires.” Bransted made the comment in response to President […]
Q&A: Rufus Edmisten on how Watergate compares to today's politics, civility
At age 85, Rufus Edmisten has had one of the longest and most colorful careers of any living figure in North Carolina politics. As a young aide to U.S. Sen. Sam Ervin, he delivered the subpoena for the Nixon tapes in the Senate’s Watergate investigation. Then he came back to North Carolina and served as attorney general and secretary of state.
Packers' Nixon says hamstring tightness caused him to miss first practice
The 29-year-old Nixon started all 18 games (including playoffs) last season and was named to the NFC’s Pro Bowl team as an alternate.
Science can serve dark as well as light
I’m not sure how many of you are watching “Star City,” Apple TV’s spin-off of its “For All Mankind” program (2019-present), but it’s one of the better sci-fi series I’ve seen in a while, with an impressively dark political message. (Some light spoilers below.) For the uninitiated, “For All Mankind” presented a slightly tweaked history of the U.S. space program in which it was the USSR that landed on the Moon first in 1969, and shortly thereafter put a woman cosmonaut on the lunar surface. This sparks an ongoing space race that, in the original series, yields a lot of benefits for humanity. President Nixon’s insistence on a female astronaut corps to compete with the Soviets boosts the feminist movement of the 1970s and the ERA passes. New fuels generated for the space program create clean and cheap energy around Earth. There are also some darker changes — the USSR is thriving well into the 2000s, there are terrorist counter-technology movements around the globe, laborers on Mars work in nightmarish conditions and organize strikes and riots, etc. the @smotus report is a reader-supported publication. To support this work, please become a paid subscriber. Subscribe That show offers glimpses into the subtle ways this Earth is different. Teddy Kennedy never went to Chappaquidick because he was racing back to Washington to deal with the space program crisis; he gets elected President in 1972. John Lennon survives his early 1980s shooting but Pope John Paul II does not. The Apple Newton succeeded. Pretty much the whole of season 4 is a setup for an Al Gore joke. Again, mostly, the vision that “For All Mankind” presents is a positive one, with technology advancing many human interests. “Star City” goes in a very different direction. This spin-off show is about the same set of events but from the Soviet perspective. As we meet them, the team of scientists and cosmonauts responsible for the lunar landing are still basking in their hero status, but their program is embedded deep in the Soviet security state of the late 1960s. Everyone’s apartment is bugged. Whole teams of clerical staff spend their days transcribing recordings of people’s lives. People in the program, including respected cosmonauts, are regularly arrested. An incredibly menacing Colonel Lyudmilla Raskova (Anna Maxwell Martin) forces confessions and tortures and kills, expressing little more than annoyance in the process. Meanwhile, the space program’s highly respected Chief Designer (Rhys Ifans) has a vision for the program that he knows the government will not approve. He insists that they need to think past the Moon to focus on colonizing the solar system, starting with Venus. (This is a rough parallel to the Americans’ pivot to Mars in the original show.) He essentially builds a secret space program within the space program, calculating that the government will embrace the mission after it has succeeded. (As an aside, I’m not sure why the Venus obsession, as a successful mission can’t produce the biggest public relations payoff: a cosmonaut standing on the surface holding the Soviet flag. Anyone standing on Venus would be immediately crushed by the 92-bar atmosphere and then cremated in the 900°F temperatures. But in a country with no free press perhaps the visual payoff was less valued.) But the overall vision is that the technological advances have only amplified the most fearsome aspects of the Soviet system. The state is paranoid (but not incorrect) about American spies and does monstrous things to protect its secrets. People are terrified to trust each other. Classic banality-of-evil figures order people to harm those they care about; those people comply rather than get shot. Others are forced into criminal behavior to protect loved ones. We’re reminded all the time these days of what happens when a government despises science. It manifests in the defunding of schools, the elevation of fossil fuels as the rest of the world pivots to solar, outbreaks of measles and diarrhea, etc. But “Star City” offers a vision of a bad government that likes science. It’s not encouraging. It’s not yet clear if there will be a season two of this show. But I strongly recommend season one. It’s both thoughtful and gripping. Share
Sen. Mitch McConnell’s constituents deserve transparency
Mitch McConnell's health, Nixon’s war on drugs, 'Take Me Home, Country Roads' and more, in readers' eyes.
Trump gives his take on Taft, Nixon, Obama in Usha Vance interview
On the second lady’s podcast aimed at promoting child literacy, Trump also said the country is “on a little bit of a ledge right now.”
Conservatives revolt after Trump-appointed Barrett joins liberals in ‘shockingly wrong’ mail ballot ruling
Amy Coney Barrett faces conservative backlash after authoring the 5-4 Supreme Court ruling allowing mail-in ballots received after Election Day.
Why JD Vance is downplaying Richard Nixon’s corruption
It’s not every day that you see the would-be frontrunner for a major party’s presidential nomination extolling the virtues of Richard Nixon and downplaying his corruption.
Vance Downplays Watergate and Compares Himself to Nixon
The vice president said that the scandal that ended Richard Nixon’s presidency would be “like a 12-hour news story” if it happened today and that the “deep state” had taken down Nixon.
Vance dismisses Watergate scandal, says ‘deep state’ went after Nixon
The vice president said he admired Nixon and drew parallels between the past president, who resigned amid pressure in 1974, and Trump today.
JD Vance says Nixon’s Watergate scandal would be ‘12-hour news story’ today
Vice-president declares admiration for 37th president and claims Nixon and Trump targeted by ‘deep state’ forces
Vance, an admirer of Richard Nixon, says Watergate would be 'a 12-hour news story' today
Vice President JD Vance says the Watergate scandal that brought down President Richard Nixon would have been a blip in today’s news cycle
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
First-ever historical marker in Tift County honoring Black business legacy to be dedicated
The Georgia Historical Society will dedicate a historical marker honoring Frank T. Nixon and Solomon Nixon Sr.
From tennis to T-ball, the White House's South Lawn is no stranger to sports. But not like the UFC
WASHINGTON (AP) — Teddy Roosevelt boxed. Richard Nixon bowled.
Packers’ Keisean Nixon facing backlash after blunt words for Bears
The 2026 NFL season is still months away, but the rivalry between the Green Bay Packers and the Chicago Bears never stops. It simply does not take a pause. Just recently, Packers defensive back Keisean Nixon further fueled that with a statement on Chicago. Via Dave Schroeder of WBAY-TV: Keisean Nixon on the Bears: “Free [...]
Winner and Loser of the Week in Florida politics
There's progress on the Rays stadium deal, while Alex Otaola and Angie Nixon put on a bipartisan display of ineptitude.
'Petty politics': Angie Nixon blames Ron DeSantis and 'his allies' for House discipline over megaphone use
The Jacksonville Democrat shows no remorse or regret for violating House rules last month.
Megaphone mistake: Angie Nixon reprimanded for interfering with redistricting vote
Chair Sam Garrison deemed the ruling a 'measured response.'
Barnes & Thornburg adds entertainment trio from Nixon Peabody
Barnes nabs entertainment trio from Nixon Peabody; Christina Change and Carron Joan Mitchell join Barnes in Los Angeles, while Farrah Usmani joins its Nashville location
How Disneyland Remade American Politics
America is turning 250, and The Free Press is marking the occasion with a yearlong series of events, conversations, and stories celebrating our country’s history. Today, we’re taking a journey with historian Beverly Gage to Southern California. Beverly traded the archives for the open road for her new book, This Land is Your Land: A Road Trip Through U.S. History. We’re proud to publish an excerpt, on the theme park that shaped American politics—and the presidents who loved it. —The Editors On July 17, 1955, Ronald Reagan stood near a mocked-up wood-plank town in Anaheim, California, where a 13-star flag flew incongruously over an “Old West” landscape, and introduced the world to Disneyland. He had been invited by Walt Disney himself to co-host the park’s live ABC broadcast, alongside Art Linkletter and Bob Cummings—three Hollywood actors who seemed to embody a wholesome, all-American ethos. From the imagined past of Frontierland, the show leaped ahead to Tomorrowland, set in the far-off year of 1986, emphasizing the technical marvels yet to come: nuclear energy harnessed for civilian purposes, human beings riding rocket ships into space. Disney foretold great things for a 1980s in which the United States would serve as “a source of joy and inspiration to all the world.” But even he could not predict the most important political fact of the age: that his genial co-host would become president. Southern California was a strange place to build a park about the past, because the region at the time was all about newness and abundance and growth. For a lot of its history, Orange County had been Southern California’s version of flyover country: a vast agricultural expanse between two desirable places, Los Angeles and San Diego. But Disneyland was changing that. Before long, 50 miles south of deep-blue Hollywood, Orange County would become a region famed for its right-wing politics—but also for its mythmaking skills. Those two things, it turned out, went naturally together. ADVERTISEMENT The two presidents Southern California gave America both understood this instinctively. Richard Nixon and Reagan each built a national career on invoking a version of the American past in which the specificities of historical context mattered less than the big picture. For Nixon, progress meant proclaiming a “New American Revolution” on the eve of America’s bicentennial while dismantling the federal programs that had built the postwar middle class. For Reagan, it meant recapturing a lost optimism and an old-fashioned faith in America as an exceptional nation. Both men were less interested in history as it actually happened than in history as it felt—and Orange County, a place that had built itself almost entirely from scratch, turned out to be exactly where the myth of America’s future was getting made. I’m a historian—and historians tend to be myth-busters. With the country’s 250th birthday on the horizon, I figured it was a good time to step out of the ivory tower and check in with the past as it exists here and now, at the museums and monuments and roadside attractions where Americans go to learn about their history. After all my travels—to Davy Crockett’s Tennessee and Texas, to the real Erie Canal, to the birthplace of the American automobile and the actual Old West—I couldn’t miss out on Disneyland, the single most influential historic attraction in U.S. history.
How science is taking tripping mainstream
President Trump recently signed an order to speed up the evaluation of psychedelics to treat the brain. That’s coming after decades of strict prohibition on psychedelic drug use dating back to President Nixon. So how did we go from that to a psychedelic renaissance? A look into a key institution in the world of psychedelic research may give us some clues. This episode, NPR’s brain correspondent Jon Hamilton shares insight from a recent trip. (No pun intended.) Want more psychedelic content? Catch our episode on ketamine therapy here, or learn why some scientists want to take the trip out of psychedelics here. Have other questions about psychedelics and the brain? Let us know by emailing shortwave@npr.org!
Yvette Benarroch says Angie Nixon's bullhorn protest left her with possible ear damage, files workers’ comp claim
'When we go on the floor like we shouldn't be afraid of getting hurt, especially by another member.'
Ashley Moody, Alex Vindman will both face Primary battles to get on November ballot
Angie Nixon will face off with Vindman for the Democratic nomination while four other Republicans joined a GOP Primary with Moody.
Trump Family Deal Spree Could Open Door for Future Presidents to Profit From Office
NEW YORK (AP) — For decades, presidents avoided even the appearance of profiting from their office. Harry Truman refused to lend his name to any business, even in retirement. Richard Nixon so feared a brother might profit off their ties, he had his phone tapped. And George W. Bush dumped his ...
Manatt Recruits Nixon Peabody Entertainment Group Chief Heisler
Entertainment lawyers Ellie Heisler, Jessica Boardman, and Mike Lawhead joined Manatt, Phelps & Phillips as partners in Los Angeles, the firm announced Tuesday.
MOSI exhibition 'Dreaming in Bamboo' highlights blend of science and art
Artist Alexander Nixon knew that the Museum of Science and Innovation (MOSI) was the perfect home for his collection "Dreaming in Bamboo."
Alexander Butterfield, Who Revealed Nixon Tapes in Watergate Scandal, Dies at 99
“There is tape in the Oval Office,” said Mr. Butterfield, a former White House aide, in testimony that rocked the Watergate hearings and led to the president’s resignation.
Jacksonville Bold for 1.21.26: Nixon’s next move
Jacksonville politics churn as ambitions, scandals, and legislation collide heading into 2026.
Stuart Altman, former Brandeis president and economic adviser to US presidents, dies at 88
In various capacities, Stuart Altman was an adviser in the administrations of five presidents: Lyndon Johnson, Richard Nixon, Bill Clinton, Barack Obama, and Joe Biden.
Angie Nixon still mulling political future as 2026 nears
Compounding Nixon’s Senate hopes, and likely fueling her delay in making a decision, is a difficult, if not nonexistent, path to victory statewide.
Mulvaney addresses future of politics and populism at Brooks School event
Director Mick Mulvaney, the 2025–26 Nixon Distinguished Policy Fellow, delivered a keynote on the rise of populism in America to a full lecture hall of Cornell students, highlighting shifts in U.S. politics and engaging in wide-ranging discussion on contemporary policy challenges.